Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Breast implant litigation

This article was originally published in The Gray Sheet

Executive Summary

State supreme court in California upholds the dismissal of 1,800 silicone breast implant suits against Dow Chemical, affirming prior decisions in 1994 by a San Diego trial court and in 1996 by a California appeals court. The 6-1 vote rules that Dow Chemical "owed no duty to breast implant plaintiffs" because physical harm was "unforeseeable" in the company's silicone toxicology research for Dow Corning. Separately, a federal court judge in Michigan accepts a revised $3.2 bil. liability settlement agreement between Dow Corning and plaintiffs involved in breast implant liabilities class action lawsuit against the company (see related story p. 11)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts